Latest Breaking News On - Syndax pharmaceuticals price performance - Page 1 : comparemela.com

Syndax Pharmaceuticals (NASDAQ:SNDX) Receives Overweight Rating from JPMorgan Chase & Co

Syndax Pharmaceuticals (NASDAQ:SNDX) Receives Overweight Rating from JPMorgan Chase & Co
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesStifel nicolausSyndax pharmaceuticals incNews ratings for syndax pharmaceuticals dailySyndax pharmaceuticals company profileSei investments coAnalyst recommendations for syndax pharmaceuticalsSyndax pharmaceuticalsJpmorgan chase coSyndax pharmaceuticals price performanceYork state common retirement fundFree reportModerate buyGet free reportRetirement system

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3 7%

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3 7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSyndax pharmaceuticals incSyndax pharmaceuticalsChina universal asset management coInstitutional trading of syndax pharmaceuticalsJpmorgan chase coNews ratings for syndax pharmaceuticals dailySyndax pharmaceuticals price performanceSei investments coSyndax pharmaceuticals company profileYork state common retirement fundGet free reportRetirement systemState retirement systemUniversal asset management

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by HC Wainwright

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSyndax pharmaceuticals incSg americas securitiesSyndax pharmaceuticals price performanceChina universal asset management coJpmorgan chase coMirae asset global investments coNews ratings for syndax pharmaceuticals dailyInstitutional trading of syndax pharmaceuticalsYelin lapidot holdings management ltdAnalyst recommendations for syndax pharmaceuticalsSyndax pharmaceuticalsFree reportModerate buyGet free reportAsset global investments

Syndax Pharmaceuticals (SNDX) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $41.00 target price on the stock. A number of other analysts also recently commented on the stock. StockNews.com upgraded shares of Syndax Pharmaceuticals to a sell […]

United statesManufacturers life insurance companyAnalyst recommendations for syndax pharmaceuticalsMirae asset global investments coCommonwealth equity servicesSyndax pharmaceuticals incSyndax pharmaceuticalsSyndax pharmaceuticals price performanceNews ratings for syndax pharmaceuticals dailyAmeritas investment partners incFree reportModerate buyGet free reportEquity servicesInvestment partnersAsset global investments

Syndax Pharmaceuticals (NASDAQ:SNDX) Announces Earnings Results

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.99) by ($0.01), Briefing.com reports. During the same period in the prior year, the business posted ($0.62) earnings per share. Syndax Pharmaceuticals Price Performance NASDAQ:SNDX traded […]

Earnings history for syndax pharmaceuticalsSyndax pharmaceuticalsSyndax pharmaceuticals incNews ratings for syndax pharmaceuticals dailySyndax pharmaceuticals price performanceVanguard group incBlackrock incHedge funds weigh in on syndax pharmaceuticalsHealthcare of ontario pension plan trust fundSyndax pharmaceuticals company profileGet free reportOntario pension plan trust fundSyndax pharmaceuticals daily